Price
CHART BY
Historical dividends and forecast
IRadimed has so far distributed $0.20 in 2026. The next dividend will be paid on 30.05.2026
$1.122
CHART BY
Frequently asked questions
What is IRadimed's market capitalization?
The market capitalization of IRadimed is $1.08B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is IRadimed's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for IRadimed is 48.31. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for IRadimed?
IRadimed's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.749. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for IRadimed's stock?
Currently, 3 analysts cover IRadimed's stock, with a consensus target price of $118.67. Analyst ratings provide insights into the stock's expected performance.
What is IRadimed's revenue over the trailing twelve months?
Over the trailing twelve months, IRadimed reported a revenue of $83.81M.
What is the EBITDA for IRadimed?
IRadimed's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $27.31M. EBITDA measures the company's overall financial performance.
What is the free cash flow of IRadimed?
IRadimed has a free cash flow of $17.18M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does IRadimed have, and what sector and industry does it belong to?
IRadimed employs approximately 166 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of IRadimed's shares?
The free float of IRadimed is 8.27M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $1.08B
- EPS (TTM)
- $1.749
- Free Float
- 8.27M
- P/E ratio (TTM)
- 48.31
- Revenue (TTM)
- $83.81M
- EBITDA (TTM)
- $27.31M
- Free Cashflow (TTM)
- $17.18M
Pricing
- 1D span
- $82.70$85.35
- 52W span
- $50.37$107.67
Analyst Ratings
The price target is $118.67 and the stock is covered by 3 analysts.
Buy
3
Hold
0
Sell
0
Information
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Orlando, FL.
- Employees
- 166
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- Primary Ticker
- IRMD
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet